1. Home
  2. BIOA vs POET Comparison

BIOA vs POET Comparison

Compare BIOA & POET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BioAge Labs Inc.

BIOA

BioAge Labs Inc.

HOLD

Current Price

$21.13

Market Cap

856.3M

Sector

Health Care

ML Signal

HOLD

Logo POET Technologies Inc.

POET

POET Technologies Inc.

HOLD

Current Price

$6.60

Market Cap

959.0M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
BIOA
POET
Founded
2015
1972
Country
United States
Canada
Employees
64
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Semiconductors
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
856.3M
959.0M
IPO Year
N/A
2008

Fundamental Metrics

Financial Performance
Metric
BIOA
POET
Price
$21.13
$6.60
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
$51.80
N/A
AVG Volume (30 Days)
448.5K
6.8M
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$2,939.08
Revenue Next Year
$898.47
$710.17
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.88
$3.10
52 Week High
$24.00
$9.41

Technical Indicators

Market Signals
Indicator
BIOA
POET
Relative Strength Index (RSI) 55.10 50.78
Support Level $18.62 $5.05
Resistance Level $22.25 $7.42
Average True Range (ATR) 1.42 0.63
MACD -0.13 0.05
Stochastic Oscillator 67.45 31.61

Price Performance

Historical Comparison
BIOA
POET

About BIOA BioAge Labs Inc.

Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases, such as obesity, by targeting the biology of human aging. Its focus is metabolic disease, one of the greatest healthcare challenges. The pipeline Products of the company are NLRP3 inhibitors, APJ against, and others.

About POET POET Technologies Inc.

POET Technologies Inc is a design and development company offering high-speed optical engines, light source products, and custom optical modules to the artificial intelligence systems market and hyperscale data centers. Its integration solutions are based on the POET Optical Interposer, a novel, patented platform that allows the seamless integration of electronic and photonic devices into a single chip using wafer-level semiconductor manufacturing techniques. POET's Optical Interposer platform also solves device integration challenges across a broad range of communication, computing, and sensing applications. The company operates geographically in the United States, Canada, Singapore and China.

Share on Social Networks: